Mechanistic Characterization of Cancer-associated Fibroblast Depletion via an Antibody-Drug Conjugate Targeting Fibroblast Activation Protein.
Gallant JP, Hintz HM, Gunaratne GS, Breneman MT, Recchia EE, West JL, Ott KL, Heninger E, Jackson AE, Luo NY, Rosenkrans ZT, Hernandez R, Zhao SG, Lang JM, Meimetis L, Kosoff D, LeBeau AM.
Gallant JP, et al. Among authors: jackson ae.
Cancer Res Commun. 2024 Jun 12;4(6):1481-1494. doi: 10.1158/2767-9764.CRC-24-0248.
Cancer Res Commun. 2024.
PMID: 38747612
Free PMC article.